GPC3 and hepatocellular carcinoma: Nakano et al. successfully generated a chimeric anti-glypican 3 (GPC3) mAb able to induce not only ADCC against GPC3-positive human HCC cells but it was also efficacious against a Huh-7 human HCC xenograft [101].